Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of LY06006 in postmenopausal osteoporosis at high fracture risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• LY06006

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: UNKNOWN